AbCellera Results Presentation Deck

Q1 2023 BUSINESS UPDATE COPYRIGHT © ABCELLERA 5 TECHNOLOGY DEVELOPMENT. T-Cell Engager Platform Solving key challenges in developing T-cell engager cells and specific immune cells called T cells. TCEs T-cell engagers (TCEs) are antibodies with 2 arms that are designed to bind to cancer cancer treatments. work by bringing T cells and cancer cells together and stimulating the T cells to kill the cancer cells. controlling how T cells are activated For the arm that binds to the T cell, the goal is to balance potency & cytokine release. only targeting cancer cells For the arm that binds to the cancer cell, the goal is to target only cancer cells, and not healthy cells.

View entire presentation